News

• 10 Jan, 2023
  Spago Nanomedical publishes scientific paper on positive preclinical data with Tumorad® as treatment of solid tumors
• 23 Dec, 2022
  Spago Nanomedical avslutar avtal om likvididtetsgaranti
• 23 Dec, 2022
  Spago Nanomedical terminates liquidity guarantee
• 8 Dec, 2022
  Första patienten doserad i Spago Nanomedicals kliniska fas IIa-studie i endometrios
• 8 Dec, 2022
  First patient dosed in Spago Nanomedical’s endometriosis Phase IIa clinical study
• 6 Dec, 2022
  Spago Nanomedical inleder klinisk studie med SpagoPix i endometrios och avslutar SPAGOPIX-01
• 6 Dec, 2022
  Spago Nanomedical initiates clinical trial with SpagoPix in endometriosis and concludes SPAGOPIX-01
• 8 Nov, 2022
  Spago Nanomedical delårsrapport januari-september 2022
• 8 Nov, 2022
  Spago Nanomedical interim report January-September 2022
• 20 Oct, 2022
  Valberedning utsedd inför Spago Nanomedicals årsstämma 2023